Bourgier C, Boisbouvier S, Bayart É, Chamois J, Clavère P, Corbin S, De Oliveira A, Hannoun-Lévi J-M, Hasbini A, Geffroy-Hulot C, Le Tallec P, Monpetit É, Santini J-J [Radiation therapists shortage in France: Organizational consequences and difficulties in deploying new missions and/or tasks delegation]. Cancer Radiother. 2023;27(6-7):577-582. doi:10.1016/j.canrad.2023.07.007
Bollet M, Racadot S, Rivera S, Arnaud A, Bourgier C [Breast cancer radiation therapy: Current questions in 2023]. Cancer Radiother. 2023;27(6-7):524-530. doi:10.1016/j.canrad.2023.07.005
Aristei C, Kaidar-Person O, Boersma L, Leonardi M, Offersen B, Franco P, Arenas M, Bourgier C, Pfeffer R, Kouloulias V, Bölükba?? Y, Meattini I, Coles C, Luis A, Masiello V, Palumbo I, Morganti A, Perrucci E, Tombolini V, Krengli M, Marazzi F, Trigo L, Borghesi S, Ciabattoni A, Rato?a I, Valentini V, Poortmans P The 2022 Assisi Think Tank Meeting: White paper on optimising radiation therapy for breast cancer. Crit Rev Oncol Hematol. 2023;187. doi:10.1016/j.critrevonc.2023.104035
Danieli R, Pistone D, Tranel J, Botta F, Uribe?Munoz C, Raspanti D, Salvat F, Wilderman S, Bardiès M, Amato E, Dewaraja Y, Cremonesi M Technical note: Impact of dose voxel kernel (DVK) values on dosimetry estimates in 177 Lu and 90 Y radiopharmaceutical therapy (RPT) applications. Medical Physics. 2023-09-15. doi:10.1002/mp.16729
Pouget J-P, Chan T, Galluzzi L, Constanzo J Radiopharmaceuticals as combinatorial partners for immune checkpoint inhibitors. Trends Cancer. 2023;9(11):968-981. doi:10.1016/j.trecan.2023.07.014
Gueiderikh A, Sarrade T, Kirova Y, Auzac G, Martin A, Everhard S, Meillan N, Benyoucef A, Lacornerie T, Pasquier D, Racadot S, Moignier A, Paris F, André F, Deutsch E, Duchemann B, Allodji R, Rivera S Radiation-induced lung injury after breast cancer treatment: incidence in the CANTO-RT cohort and associated clinical and dosimetric risk factors. Front Oncol. 2023;13. doi:10.3389/fonc.2023.1199043
Bardiès M Quality assurance in clinical dosimetry. Hell J Nucl Med. 2023;26 Suppl.
Kayal G, Barbosa N, Calderón Marín C, Ferrer L, Fragoso-Negrín J-A, Grosev D, Gupta S, Hidayati N, Moalosi T, Poli G, Thakral P, Tsapaki V, Vauclin S, Vergara-Gil A, Knoll P, Hobbs R, Bardiès M Quality Assurance Considerations in Radiopharmaceutical Therapy Dosimetry Using PLANETDose: An International Atomic Energy Agency Study. J Nucl Med. 2023-10-26. doi:10.2967/jnumed.122.265340
Cusumano C, Deshayes E, Guiu B, De Meeus G, Carrère S, Bouillin A, Ilonca D, Éberlé M, Guillemard S, Fersing C, Sgarbura O, Quénet F Prevention of post-hepatectomy liver failure after major resection of colorectal liver metastases: is hepato-biliary scintigraphy the optimal tool?. Ann Transl Med. 2023;11(5):202-202. doi:10.21037/atm-22-3665
Taprogge J, Vergara-Gil A, Leek F, Abreu C, Vávrová L, Carnegie-Peake L, Schumann S, Eberlein U, Lassmann M, Schurrat T, Luster M, Verburg F, Vallot D, Vija L, Newbold K, Bardiès M, Flux G Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD project. Eur J Nucl Med Mol Imaging. 2023;50(11):3225-3234. doi:10.1007/s00259-023-06295-0
Deshayes E, Fersing C, Thibault C, Roumiguie M, Pourquier P, Houédé N Innovation in Radionuclide Therapy for the Treatment of Prostate Cancers: Radiochemical Perspective and Recent Therapeutic Practices. Cancers. 2023;15(12):3133. doi:10.3390/cancers15123133
Constanzo J, Bouden Y, Godry L, Kotzki P-O, Deshayes E, Pouget J-P Immunomodulatory effects of targeted radionuclide therapy. Int Rev Cell Mol Biol. 2023;378. doi:10.1016/bs.ircmb.2023.02.001
Galvez T, Berkane I, Eberlé M-C, Flori N, Guillemard S, Ilonca A, Santoro L, Kotzki P-O, Senesse P, Deshayes E Identification of 18F-FDG PET/CT Parameters Associated with Weight Loss in Patients with Esophageal Cancer. Nutrients. 2023;15(13):3042. doi:10.3390/nu15133042
Garcia-Prada C, Carmes L, Atis S, Parach A, Bertolet A, Jarlier M, Poty S, Garcia D, Shin W-G, Schuemann J, Tillement O, Lux F, Constanzo J, Pouget J-P Gadolinium-Based Nanoparticles Sensitize Ovarian Peritoneal Carcinomatosis to Targeted Radionuclide Therapy. J Nucl Med. 2023-10-19. doi:10.2967/jnumed.123.265418
Mangeat T, Gracia M, Pichard A, Poty S, Martineau P, Robert B, Deshayes E Fc-engineered monoclonal antibodies to reduce off-target liver uptake. EJNMMI Res. 2023;13(1):81. doi:10.1186/s13550-023-01030-0
Sjögreen-Gleisner K, Flux G, Bacher K, Chiesa C, de Nijs R, Kagadis G, Lima T, Georgosopoulou M, Nekolla S, Peters S, Santos J, Sattler B, Stokke C, Tran-Gia J, Gilligan P, Bardiès M EFOMP policy statement NO. 19: Dosimetry in nuclear medicine therapy - Molecular radiotherapy. Phys Med. 2023-11-03. doi:10.1016/j.ejmp.2023.103166
Le Bras A, Belkacemi Y, Gabelle-Flandin I, Petit A, Guilbert P, Geffrelot J, Rivin Del Campo E, Hanzen C, Charra Brunaud C, Auzac G, Lacornerie T, Lartigau E, Durand-Zaleski I Economic evaluation and budget-impact of accelerated partial breast irradiation (APBI) versus standard or hypofractionated whole breast irradiation (WBI) in postmenopausal women with early-stage breast cancer. Results from the French SHARE randomized trial. Radiother Oncol. 2023;187. doi:10.1016/j.radonc.2023.109818
Maïmoun L, Alonso S, Mahadea K, Boudousq V, Mura T, Mariano-Goulart D Cross-Calibration Study of The Stratos And Hologic QDR 4500A Dual-Energy X-Ray Absorptiometers to Assess Bone Mineral Density And Body Composition. J Clin Densitom. 2023;26(4):101434. doi:10.1016/j.jocd.2023.101434
Maïmoun L, Mahadea K, Alonso S, Chevallier T, Kotzki P, Mura T, Boudousq V Comparison of the Discovery A and Stratos DR densitometers for assessing whole?body and regional bone mineral density and body composition. Clin Physio Funct Imaging. 2023;43(5):382-392. doi:10.1111/cpf.12836
Constanzo J, Garcia-Prada C, Pouget J-P Clonogenic assay to measure bystander cytotoxicity of targeted alpha-particle therapy. Methods Cell Biol. 2023;174. doi:10.1016/bs.mcb.2022.08.005
Sarrade T, Allodji R, Ghannam Y, Auzac G, Everhard S, Kirova Y, Peignaux K, Guilbert P, Pasquier D, Racadot S, Bourgier C, Ducornet S, André F, Rivera S CANTO-RT: One of the Largest Prospective Multicenter Cohort of Early Breast Cancer Patients Treated with Radiotherapy including Full DICOM RT Data. Cancers (Basel). 2023;15(3):751. doi:10.3390/cancers15030751
Allali S, Carton M, Everhard S, Rivera S, Ghannam Y, Peignaux K, Guilbert P, Chara-Brunaud C, Blanchecotte J, Pasquier D, Racadot S, Bourgier C, Cottu P, André F, Kirova Y CANTO skin: Evaluation of skin toxicity risk factors in patients treated for breast cancer. Int J Cancer. 2023;153(10):1797-1808. doi:10.1002/ijc.34664
Pouget J-P, Konijnenberg M, Eberlein U, Glatting G, Gabina P, Herrmann K, Holm S, Strigari L, van Leeuwen F, Lassmann M An EANM position paper on advancing radiobiology for shaping the future of nuclear medicine. Eur J Nucl Med Mol Imaging. 2023;50(2):242-246. doi:10.1007/s00259-022-05934-2
Maïmoun L, Gelis A, Serrand C, Mura T, Humbert L, Boudousq V, Laux D, Fattal C, Mariano-Goulart D Alteration of Volumetric Bone Mineral Density Parameters in Men with Spinal Cord Injury. Calcif Tissue Int. 2023;113(3):304-316. doi:10.1007/s00223-023-01110-2
Rouanet P, Castan F, Mazard T, Lemanski C, Nougaret S, Deshayes E, Chalbos P, Gourgou S, Taoum C GRECCAR 14 - a multicentric, randomized, phase II - III study evaluating the tailored management of locally advanced rectal carcinoma after a favourable response to induction chemotherapy: Study protocol. Colorectal Disease. 2023;25(10):2078-2086. doi:10.1111/codi.16740
Institut de Recherche en Cancérologie de
